Texas Children’s Global Health Stories


Adam Gibson Adam Gibson

Texas Children’s CORBEVAX COVID-19 Vaccine receives Emergency Use Authorization

Texas Children’s and Baylor College of Medicine announced on December 28, that CORBEVAX, a protein sub-unit COVID-19 Vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use Authorization (EUA) approval from the Drugs Controller General of India (DCGI) to launch first in India, with other underserved countries to follow.

Read More
Catriona Gates Catriona Gates

Johnson & Johnson’s COVID-19 vaccine: Answering the big questions

As a vaccine developer and researcher, I’m incredibly encouraged by the progress made thus far as we continue in our fight against COVID-19. Following the recent news regarding this third vaccine, I wanted to share some of the most common questions about Johnson & Johnson’s vaccine.

Read More